RenaSci Consultancy Limited - Limited company - abbreviated - 11.6
RenaSci Consultancy Limited - Limited company - abbreviated - 11.6
REGISTERED NUMBER: |
Abbreviated Unaudited Accounts |
for the Year Ended 31 March 2015 |
for |
RenaSci Consultancy Limited |
RenaSci Consultancy Limited (Registered number: 04157254) |
Contents of the Abbreviated Accounts |
for the Year Ended 31 March 2015 |
Page |
Company Information | 1 |
Abbreviated Balance Sheet | 2 |
Notes to the Abbreviated Accounts | 3 |
RenaSci Consultancy Limited |
Company Information |
for the Year Ended 31 March 2015 |
DIRECTORS: |
SECRETARY: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
ACCOUNTANTS: |
Chartered Accountants |
and Business Advisers |
RenaSci Consultancy Limited (Registered number: 04157254) |
Abbreviated Balance Sheet |
31 March 2015 |
2015 | 2014 |
Notes | £ | £ |
CURRENT ASSETS |
Debtors |
TOTAL ASSETS LESS CURRENT LIABILITIES |
CAPITAL AND RESERVES |
Called up share capital | 2 |
SHAREHOLDERS' FUNDS |
The directors acknowledge their responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
The financial statements were approved by the Board of Directors on behalf by: |
RenaSci Consultancy Limited (Registered number: 04157254) |
Notes to the Abbreviated Accounts |
for the Year Ended 31 March 2015 |
1. | ACCOUNTING POLICIES |
Accounting convention |
The financial statements have been prepared under the historical cost convention and in accordance with the |
Financial Reporting Standard for Smaller Entities (effective April 2008). |
The company was dormant throughout the current year and previous year. |
Deferred tax |
The charge for taxation takes into account taxation deferred as a result of timing differences between the |
treatment of certain items for taxation and accounting purposes. In general, deferred taxation is recognised |
in respect of all timing differences that have originated but not reversed at the balance sheet date. However, |
deferred tax assets are recognised only to the extent that the directors consider that it is more likely than not |
that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
Deferred taxation is measured on a non-discounted basis at the average tax rates that would apply when the |
timing differences are expected to reverse, based on tax rates and laws that have been enacted by the |
balance sheet date. |
Research and development |
Expenditure on research and development is written off in the year in which it is incurred, except for |
expenditure on related assets, which are disclosed in these financial statements as intangible assets, and |
written off over the expected useful life of those assets. |
Foreign currencies |
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the |
balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange |
ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating |
result. |
Government grant |
Government grants received in respect of expenditure charged to the profit and loss account during the year |
have been included in the profit and loss. The remainder are deferred and included in the profit and loss |
account by instalments over the expected useful lives of the related assets. |
2. | CALLED UP SHARE CAPITAL |
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 2015 | 2014 |
value: | £ | £ |
Ordinary | £1 |
3. | ULTIMATE PARENT COMPANY |
The company's ultimate parent undertaking at the balance sheet date is RenaSci Limited, a company |
incorporated in the United Kingdom. |